◆ Market Data --:--
⛽ Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Zentek Ltd.

ZEN.V TSXV Healthcare Medical Instruments & Supplies Guelph, Canada
Loading stock data...
Stock Performance
Price History
- Drag to select time range -
Market Data
Market Cap 92.5M
P/E Ratio -
52-Week High -
52-Week Low -
Avg Volume -
Beta -
Forward P/E -
Dividend Yield -
EV/Revenue -
Price/Book -
Business Overview

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Healthcare Medical Instruments & Supplies TSXV
Key Financial Metrics
872,495
Revenue
-10.0M
Net Income
C$-0.10
EPS (Diluted)
-6.5M
Free Cash Flow
Profitability
Gross Margin 22.1%
Operating Margin -1100.4%
Net Profit Margin -1150.7%
EBITDA -9.3M
Returns & Efficiency
Return on Assets (ROA) -54.6%
Return on Equity (ROE) -68.1%
Dividend Yield -
Payout Ratio -
Financial Health
Total Assets 18.4M
Total Debt 680,474
Debt to Equity 0.05x
Current Ratio 1.25
Company Info
IndustryMedical Instruments & Supplies
HQGuelph, Canada
Employees18
Fiscal Year End1743379200
CurrencyCAD
Websitewww.zentek.com
Peers
7.9B
P/E: --
2.5B
P/E: 12.0
2.5B
P/E: 23.7
2.2B
P/E: 53.2
1.4B
P/E: 24.1
1.2B
P/E: --
1.1B
P/E: --
631.8M
P/E: --
Insider Activity
Sentiment Bullish
Shares Bought 396,755
Shares Sold 0
Total Transactions 28
SEDAR+ Filings
View All Filings
2
Annual Reports
16
Quarterly Reports
17
MD&A
121
News Releases
23
Material Changes
2
Prospectuses
14
Governance
38
Certifications
48
Other

● Interim financial statements/report – English.pdf
2026-02-17
● Interim financial statements/report – English.pdf
2025-11-13
● Interim financial statements/report – English.pdf
2024-11-13
● Interim financial statements/report – English.pdf
2024-08-12
● Interim financial statements/report – English.pdf
2023-11-13
View all 16 quarterly reports →

● Interim MD&A - English.pdf
2026-02-17
● Interim MD&A - English.pdf
2025-11-13
● Interim MD&A - English.pdf
2024-11-13
● Interim MD&A - English.pdf
2024-08-12
● Interim MD&A - English.pdf
2023-11-13
View all 17 md&a →

● News release - English.pdf
2026-02-26
● News release - English.pdf
2026-02-25
● News release - English.pdf
2026-02-17
● News release - English.pdf
2026-01-29
● News release - English.pdf
2026-01-05
View all 121 news releases →

● Material change report - English.pdf
2025-12-11
● Material change report - English.pdf
2025-11-03
● Material change report - English.pdf
2025-09-12
● Material change report - English.pdf
2024-08-19
● Material change report - English.pdf
2022-12-08
View all 23 material changes →

● Final short form prospectus – English.pdf
2021-12-24
● Preliminary short form prospectus – English.pdf
2021-11-22

● Form of proxy - English.pdf
2024-08-26
● Management information circular - English.pdf
2024-08-26
● Form of proxy - English.pdf
2023-09-01
● Management information circular - English.pdf
2023-09-01
● Management information circular - English.pdf
2022-09-07
View all 14 governance →

● 52-109F2 - Certification of interim filings - CEO (E).pdf
2026-02-17
● 52-109F2 - Certification of interim filings - CFO (E).pdf
2026-02-17
● 52-109F2 - Certification of interim filings - CFO (E).pdf
2025-11-13
● 52-109F2 - Certification of interim filings - CEO (E).pdf
2025-11-13
● 52-109F2 - Certification of interim filings - CEO (E).pdf
2024-11-13
View all 38 certifications →

● Other.pdf
2026-01-29
● Report of Distributions outside Canada (Form 72-503F).pdf
2025-11-03
● Report of exempt distribution (45-106F1).pdf
2025-11-03
● Report of voting results.pdf
2025-09-25
● Certificate re dissemination to shareholders.pdf
2025-09-12
View all 48 other →
Interactive Charts
Full Chart View
Company Profile
General Information
Company NameZentek Ltd.
TickerZEN.V
ExchangeTSXV
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersGuelph, Canada
Employees18
Fiscal Year End1743379200
CurrencyCAD
Websitewww.zentek.com
Financial Summary
Market Cap92.5M
Revenue872,495
Net Income-10.0M
P/E RatioN/A
EPS (Diluted)C$-0.10
Net Margin-1150.7%
ROE-68.1%
Dividend YieldN/A
Business Description
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis products. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
NEWS
Loading news...
TRENDING
Loading...